BioCentury | Jun 25, 2015
Distillery Therapeutics

Therapeutics: Protein kinase B (AKT; AKT1; PKB; PKBA); phosphoinositide 3-kinase (PI3K); BRISC and BRCA1 A complex member 1 (BABAM1)

...cell lines, doxorubicin increased phosphorylation of AKT and phosphorylation of the DNA damage response protein BABAM1...
...BABAM1 and decreased viability compared with vehicle. Next steps include evaluating the phosphorylation status of BABAM1...
...TARGET/MARKER/PATHWAY: Protein kinase B (AKT; AKT1 ; PKB ; PKBA ); phosphoinositide 3-kinase (PI3K) ; BRISC and BRCA1 A complex member 1 (BABAM1)...
Items per page:
1 - 1 of 1